Published on 13 Feb 2025 on Simply Wall St. · via Yahoo Finance
Regeneron Pharmaceuticals' (NASDAQ:REGN) earnings growth rate lags the 11% CAGR...
While Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) shareholders are probably generally happy, the...
NASDAQ.REGN price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free